{"pmid": "11911755", "sentences": {"sent_1": {"Section": "", "text": "DESIGN , SETTING , AND PATIENTS : Randomized , double - blind trial of 489 inpatients with dyspnea at rest from decompensated CHF , including 246 who received pulmonary artery catheterization , that was conducted at 55 community and academic hospitals between October 1999 and July 2000 .", "entities": {"entity_1": {"text": "dyspnea", "class": "Participant", "negation": 0, "UMLS": "C0013404:dyspnea,", "index": 1, "start": 17}, "entity_2": {"text": "rest", "class": "Participant", "negation": 0, "UMLS": "", "index": 2, "start": 19}, "entity_3": {"text": "decompensated CHF", "class": "Participant", "negation": 0, "UMLS": "", "index": 3, "start": 21}, "entity_4": {"text": "pulmonary artery catheterization", "class": "Participant", "negation": 0, "UMLS": "C0007438:pulmonary artery catheterization,", "index": 4, "start": 28}, "entity_5": {"text": "community", "class": "Participant", "negation": 0, "UMLS": "", "index": 5, "start": 37}}, "relations": {}}, "sent_2": {"Section": "", "text": "INTERVENTIONS : Intravenous nesiritide ( n = 204 ) , intravenous nitroglycerin ( n = 143 ) , or placebo ( n = 142 ) added to standard medications for 3 hours , followed by nesiritide ( n = 278 ) or nitroglycerin ( n = 216 ) added to standard medication for 24 hours .", "entities": {"entity_6": {"text": "Intravenous nesiritide", "class": "Intervention", "negation": 0, "UMLS": "C0054015:nesiritide,", "index": 1, "start": 2}, "entity_7": {"text": "intravenous nitroglycerin", "class": "Intervention", "negation": 0, "UMLS": "C0017887:nitroglycerin,", "index": 2, "start": 10}, "entity_8": {"text": "placebo", "class": "Intervention", "negation": 0, "UMLS": "C0032042:placebo,", "index": 3, "start": 19}, "entity_9": {"text": "standard medications", "class": "Intervention", "negation": 0, "UMLS": "C0013227:medications,C0038137:standards,", "index": 4, "start": 27}, "entity_10": {"text": "nesiritide", "class": "Intervention", "negation": 0, "UMLS": "C0054015:nesiritide,", "index": 5, "start": 35}, "entity_11": {"text": "nitroglycerin", "class": "Intervention", "negation": 0, "UMLS": "C0017887:nitroglycerin,", "index": 6, "start": 42}, "entity_12": {"text": "standard medication", "class": "Intervention", "negation": 0, "UMLS": "C0013227:medication,C0038137:standards,", "index": 7, "start": 50}}, "relations": {}}, "sent_3": {"Section": "", "text": "MAIN OUTCOME MEASURES : Change in pulmonary capillary wedge pressure ( PCWP ) among catheterized patients and patient self - evaluation of dyspnea at 3 hours after initiation of study drug among all patients .", "entities": {"entity_13": {"text": "Change in pulmonary capillary wedge pressure ( PCWP )", "class": "Outcome", "negation": 0, "UMLS": "C0507816:pulmonary capillary,C0043091:wedge pressure,C4319952:Change,", "index": 1, "start": 4}, "entity_14": {"text": "catheterized", "class": "Participant", "negation": 0, "UMLS": "C0007430:catheterized,", "index": 2, "start": 14}, "entity_15": {"text": "patient self - evaluation of dyspnea", "class": "Outcome", "negation": 0, "UMLS": "C0220825:evaluation,C0013404:dyspnea,C1551994:self,", "index": 3, "start": 17}}, "relations": {}}, "sent_4": {"Section": "", "text": "Secondary outcomes included comparisons of hemodynamic and clinical effects between nesiritide and nitroglycerin at 24 hours .", "entities": {"entity_16": {"text": "comparisons of hemodynamic", "class": "Outcome", "negation": 0, "UMLS": "C4281788:hemodynamic,", "index": 1, "start": 3}, "entity_17": {"text": "clinical effects", "class": "Outcome", "negation": 0, "UMLS": "", "index": 2, "start": 7}, "entity_18": {"text": "nesiritide", "class": "Intervention", "negation": 0, "UMLS": "C0054015:nesiritide,", "index": 3, "start": 10}, "entity_19": {"text": "nitroglycerin", "class": "Intervention", "negation": 0, "UMLS": "C0017887:nitroglycerin,", "index": 4, "start": 12}, "attribute_1": {"text": "24 hours", "class": "measure", "negation": 0, "UMLS": "", "index": 5, "start": 14}}, "relations": {}}}}